VIM and pancreatic neoplasm: We have previously reported that DCLK1 is upregulated in pancreatic tumor tissues and co-localizes with vimentin, a marker of mesenchymal lineage within premalignant PanIN lesions, suggesting that these DCLK1+ cells are of mesenchymal origin or in the process of EMT [21].